Vishwas Bidada
Vishwas Bidada

@VBidada

7 Tweets 1 reads Apr 23, 2024
1/7 Like to share few critical updates on #PCBL (Philip Carbon Black)
1. Acquisition of Aquapharm Chemicals Pvt Ltd. for a total consideration of Rs.3800 crores.
2. Promoters infusing 448 crores to fund the Acquisition.
3. Raising 700 Crores via NCD
Let go in little detail.
2/7 #PCBL through its subsidiary acquired 100% stake in Aquapharm Chemicals Pvt Ltd for a consideration of Rs.3800 Crores.
ACPL is into specialty chemicals, one of the India largest producers of Phosphonate.
It is into high margin business. (EBITDA margin of close to 20%)
3/7 For FY23, ACPL Revenue was 2045 crores and EBITDA was close to 417 Crores.
It has a manufacturing facility in India, USA, Saudi Arabia.
This acquisition is funded by Internal Accruals + outside funding.
So, let's look into it briefly.
#PCBL
4/7 #PCBL raised 700 Crores (70000 units @ Rs.100000 each) via NCD's.
Repayment Tenure is 5 years.
Rate of Interest is 8.79%
So apart from Interest payment, PCBL has an outflow of 105 crores in each year from 2025 to 2027.
and 192.5 crores each in 2028 and 2029
5/7 Recently #PCBL issued convertible warrants to Promoters. Issued 1.6 crore shares @ 280 per shares to
1. Rainbow Investment Ltd
2. Quest Capital Market Ltd
3. STEL Holding Ltd.
Total consideration to be received is 448 crores.
6/7 Conclusion - This Acquisition is into completely into different foray. Management smartly moving towards high margin business.
Post acquisition topline might reach 7000 crores.
And bottom-line might hit 550 to 600 crores (PAT).
Interest Cost might go up from 90 to 150 crores
7/7 But overall, this Acquistion might turn out to be a game changing from shareholder point of view. Need to closely monitor management commentary and other developments if any.
For me it is a buy in sip stock.
#PCBL #Goenka #Midcap #Multibagger #StockMarketindia

Loading suggestions...